跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SETRELVO ustekinumab 45 mg/0.5 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
SETRELVO ustekinumab 45 mg/0.5 mL solution for injection vial
Approved
STANDARD
SETRELVO ustekinumab 45 mg/0.5 mL solution for injection vial
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
08a58cc409e2fa05
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
08a58cc409e2fa05
Product Name
SETRELVO ustekinumab 45 mg/0.5 mL solution for injection vial
Artg Id
422772
Artg Name
SETRELVO ustekinumab 45 mg/0.5 mL solution for injection vial
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2024-07-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
08a58cc409e2fa05
Type
Standard
Back to TGA Approvals
